Marest Capital’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Buy
4,264
+2,306
+118% +$687K 0.79% 11
2025
Q4
$506K Sell
1,958
-7
-0.4% -$1.59K 0.28% 20
2025
Q3
$446K Buy
1,965
+43
+2% +$8.81K 0.27% 20
2025
Q2
$402K Buy
1,922
+171
+10% +$32.9K 0.31% 13
2025
Q1
$341K Buy
1,751
+69
+4% +$14.3K 0.28% 18
2024
Q4
$380K Buy
1,682
+26
+2% +$5.8K 0.31% 16
2024
Q3
$345K Sell
1,656
-28
-2% -$5.63K 0.29% 16
2024
Q2
$317K Hold
1,684
0.28% 15
2024
Q1
$311K Buy
1,684
+10
+0.6% +$1.86K 0.29% 20
2023
Q4
$304K Buy
+1,674
New +$290K 0.31% 16

Other funds holding MSGS

Marest Capital's MSGS Position: Q1 2026 in Review

Marest Capital increased its Madison Square Garden (MSGS) stake by 118% in Q1 2026, buying an estimated $687K and bringing the position to 4,264 shares worth $1.37M. The position accounts for 0.79% of the portfolio, ranked #11.

Marest Capital first reported a position in MSGS in Q4 2023 and has held it in 10 quarters since. 408 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • Marest Capital held 4,264 shares of Madison Square Garden worth $1.37M as of Q1 2026.
  • Marest Capital bought 2,306 Madison Square Garden shares in Q1 2026, an estimated $687K.
  • Madison Square Garden made up 0.79% of Marest Capital's portfolio in Q1 2026, its #11 holding.
  • Marest Capital first reported a position in Madison Square Garden in Q4 2023 and has held it in 10 quarters since.
  • 408 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on Marest Capital's 13F filing for Q1 2026, filed 11 May 2026.